The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
December 25th 2023
Our most-read content that featured lung cancer included articles on non–small cell lung cancer, how navigation programs can increase screening rates, and a potential link between antidepressants and lung cancer risk.
December 14th 2023
Assessing Tobacco Exposure Among Former Smokers Eligible for Lung Cancer Screening
May 26th 2022Results of a cross-sectional study showed former smokers eligible for lung cancer screening should be asked about recent tobacco use and exposure, while counseling about the harms of these 2 risk factors is warranted.
Read More
Study Finds Rural Residence May Adversely Influence Lung Cancer Screening Among Veterans
May 12th 2022Veterans residing in rural areas were less likely to complete annual repeat lung cancer screenings compared with those living in a nonrural location, with reduced uptake of initial lung cancer screening also found among eligible veterans in rural vs nonrural locations.
Read More
Study Finds Risk of Overinvestigation in Patients With Lung Cancer Not Fit for Anticancer Treatment
April 30th 2022Among a group of patients with lung cancer who were not suitable for anticancer treatment, the researchers found that 40% underwent additional investigations after their initial CT scan before eventually receiving best supportive care.
Read More
New Study Details Frequency of SDOH Documentation Among Patients With Lung Cancer
April 22nd 2022A decade’s worth of data included more than 5 million social determinants of health (SDOH) attributes across nearly 2 million clinical notes from the patient visits extrapolated from a natural language processing system.
Read More
Dr Davey Daniel on Barriers Limiting Genomic Testing Use in Lung Cancer
April 17th 2022Davey Daniel, MD, chief medical officer, OneOncology, speaks on the knowledge, infrastructure, and payer-related barriers that are limiting the use of genomic testing in the management of patients with lung cancer.
Watch
OneOncology’s Arrowsmith Looks Forward to Real-time Dynamics in Clinical Pathways
April 14th 2022Across OneOncology, says Edward Arrowsmith MD, MPH, clinical pathways offer a vehicle for physicians to agree on best practices and to implement them across the network. Early this year, Arrowsmith became medical director for Clinical Pathways, OneOncology.
Read More
Real-world Data Show Benefits of Increased Lung Cancer Screening but Persistent Disparities
April 6th 2022Although the widespread use of low dose computed tomography screening for lung cancer has led to improved mortality in recent years, disparities in uptake persist throughout the United States.
Read More